Beranda › Kanker Payudara › Michigan › Lansing
Uji klinis Kanker Payudara di Lansing, MI
10 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Lansing (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- University of Michigan Health - Sparrow Lansing, Lansing
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
- University of Michigan Health - Sparrow Lansing, Lansing
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Menerima pesertaFase 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
E-Mindfulness Approaches for Living After Breast Cancer
Menerima pesertaFase 3
- University of Michigan Health - Sparrow Lansing, Lansing
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Menerima pesertaFase 2
- Herbert-Herman Cancer Center, Sparrow Hospital, Lansing
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Menerima pesertaFase 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
A Study of the TheraBionic P1 Device in Breast Cancer
Menerima peserta
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Lansing
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Menerima pesertaFase 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Menerima pesertaStudi observasional
- Sparrow Cancer Center, Lansing
Uji klinis Kanker Payudara di kota lain
- New York City, NY134 studi
- Houston, TX126 studi
- Boston, MA111 studi
- Nashville, TN80 studi
- Los Angeles, CA72 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Durham, NC63 studi
- Queens, NY63 studi
- Chicago, IL58 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di Lansing
- Kanker Paru11 studi
- Kanker Prostat10 studi
- Kanker Paru Non-Sel Kecil9 studi
- Kanker (semua jenis)6 studi
- Kanker Laring5 studi
- Kanker Kandung Kemih5 studi
- Gangguan Somnolen Berlebih5 studi
- Kanker Kolorektal4 studi
- Kanker Ginjal (Karsinoma Sel Renal)4 studi
- Kanker Kolon4 studi
- Karsinoma Urotelial (Sel Transisional)4 studi
- Karsinoma Sel Skuamosa Kepala dan Leher4 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.